Pulverize Yam (D. Cayennensis) supplementation in the treatment of Gestational Diabetes Mellitus

Phase 2

• Conditions: Gestational diabetes; D27.505.696.422; G07.203.300.572

• Registration Number: RBR-26ymzkc
• Lead Sponsor: niversidade Federal da Paraíba

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-04-08
• Last Update Posted: 29 April 2024
• Study Completion: 2025-01-24

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Female
• Target Recruitment: Not specified

Inclusion Criteria

Voluntary pregnant women with Gestational Diabetes Mellitus treated at the Lauro Wanderley University Hospital; over age

Exclusion Criteria

Pregnant women who are allergic to yams will be excluded; patients with kidney diseases; patients with liver or neurological diseases; pregnant women using multiple medications; minors

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
It is expected, better values in maternal and fetal nutritional parameters (maternal weight gain, baby birth weight, APGAR), clinical

Secondary Outcome Measures

Name	Time	Method
In addition to the beneficial effects on the body, it is expected that a standard dosage of supplementation with yam flour capsules will be established